• No results found

Predictive factors for outcome of rheumatoid arthritis Linden, M.P.M. van der

N/A
N/A
Protected

Academic year: 2021

Share "Predictive factors for outcome of rheumatoid arthritis Linden, M.P.M. van der"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Citation

Linden, M. P. M. van der. (2011, September 15). Predictive factors for outcome of rheumatoid arthritis. Retrieved from

https://hdl.handle.net/1887/17836

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/17836

Note: To cite this publication please use the final published version (if

applicable).

(2)

Predictive Factors for Outcome of Rheumatoid Arthritis

Michael van der Linden

Michael vd Linden bw.indd 1

Michael vd Linden bw.indd 1 01-08-11 16:0801-08-11 16:08

(3)

Lay out and printing: Optima Grafi sche Communicatie, Rotterdam, the Netherlands.

M.P.M. van der Linden, PhD Th esis (2011), Leiden University Medical Center, Leiden, the Netherlands.

Publication of this thesis was fi nancially supported by Abbott BV, Dutch Arthritis Association (Reumafonds), J.E. Jurriaanse Stichting, Merck Sharp & Dohme BV, Pfi zer BV, Roche Nederland BV, Teva Nederland BV.

Michael vd Linden bw.indd 2

Michael vd Linden bw.indd 2 01-08-11 17:2101-08-11 17:21

(4)

Predictive Factors for Outcome of Rheumatoid Arthritis

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnifi cus prof. mr. P.F. van der Heijden,

volgens besluit van het College voor Promoties te verdedigen op donderdag 15 september 2011

klokke 13.45 uur door

Michael Patrick Marcel van der Linden

geboren te Leerdam in 1978

Michael vd Linden bw.indd 3

Michael vd Linden bw.indd 3 01-08-11 16:0801-08-11 16:08

(5)

Co-promotor: Dr. A.H.M. van der Helm-van Mil

Overige leden: Prof. dr. B.A.C. Dijkmans VU Medisch Centrum, Amsterdam Prof. dr. D.M.F.M. van der Heijde Dr. K. Raza

University of Birmingham, Birmingham, UK Prof. dr. R.E.M. Toes

Michael vd Linden bw.indd 4

Michael vd Linden bw.indd 4 01-08-11 16:0801-08-11 16:08

(6)

CONTENTS

Chapter 1 General Introduction 7

Part I Methodology of analyzing RA severity data

Chapter 2 Comparison of methodology to analyze progression of joint destruc- tion in rheumatoid arthritis

Submitted

27

Part II Serology in risk prediction of RA development and severity

Chapter 3 Value of anti-MCV and anti-CCP3 compared to anti-CCP2 and rheumatoid factor in predicting disease outcome in undiff erentiated arthritis and rheumatoid arthritis

Arthritis Rheum 2009; 60 (8): 2232-2241

45

Chapter 4 Towards a data-driven evaluation of the 2010 ACR/EULAR criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor?

Arthritis Rheum 2011; 63 (5): 1190-1199

63

Chapter 5 Identifi cation of CXCL13 as marker for outcome of rheumatoid arthritis using an in silico model of the rheumatic joint

Arthritis Rheum 2011; 63 (5): 1265-1273

81

Part III Genetics in risk prediction of RA development and severity

Chapter 6 Association of the 6q23 region with the rate of joint destruction in rheumatoid arthritis

Ann Rheum Dis 2010; 69 (3): 567-570

99

Chapter 7 Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis

Arthritis Rheum 2009; 60 (8):2242-2247

111

Chapter 8 Th e PTPN22 susceptibility risk variant is not associated with the rate of joint destruction in anti-citrullinated protein antibody-positive rheumatoid arthritis

Ann Rheum Dis 2010; 69 (9): 1730-1731

121

Michael vd Linden bw.indd 5

Michael vd Linden bw.indd 5 01-08-11 16:0801-08-11 16:08

(7)

Chapter 10 Th e window of opportunity in ACPA-positive rheumatoid arthritis is not explained by ACPA characteristics

Ann Rheum Dis 2011; In press

143

Part V Subphenotypes of RA severity

Chapter 11 Repair of joint erosions in rheumatoid arthritis: prevalence and patient characteristics in a large inception cohort

Ann Rheum Dis 2010; 69 (4):727-729

151

Chapter 12 Joint damage in response to infl ammation in rheumatoid arthritis;

unraveling underlying mechanisms using extreme discordant phenotypes

Submitted

159

Part VI Discriminative ability in (development of RA and) outcome of RA

Chapter 13 Classifi cation of rheumatoid arthritis: comparison of the 1987 ACR and 2010 ACR/EULAR criteria

Arthritis Rheum 2011; 63 (1): 37-42

171

Chapter 14 Predicting arthritis outcomes - what can be learned from the Leiden Early Arthritis Clinic?

Rheumatology (Oxford) 2011; 50 (1): 93-100

185

Chapter 15 Summary and Discussion 199

Nederlandse Samenvatting 213

Dankwoord 217

Curriculum Vitae 219

Publications 221

Michael vd Linden bw.indd 6

Michael vd Linden bw.indd 6 01-08-11 16:0801-08-11 16:08

Referenties

GERELATEERDE DOCUMENTEN

Moreover, in an independent cohort relatively high serum CXCL13 levels were also associated with an enhanced progression of the rate of joint destruction over 7 years and a

2,3 From 1998 to 2002 patients were promptly treated with either sulphasalazine or methotrexate (early treatment) and patients included in 2002 or later were promptly treated

A recent meta-analysis on two genome-wide association studies identified six new risk loci rs4810485 CD40, rs1678542 KIF5A-PIP4K2C, rs42041 CDK6, rs2812378 CCL21, rs4750316 PRKCQ

2-5 Th e present study studied the eff ect of the PTPN22 susceptibly risk variant on the rate of joint destruction in two large cohorts of ACPA+ patients, using sensitive

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden. Downloaded

69% of RA patients were assessed in ≥12 weeks; this was associated with a hazard ratio of 1.87 for not achieving DMARD-free remission and a 1.3 times higher rate of joint

70 ACPA-positive patients (22.7%) presented <12 weeks (median aft er 8 weeks of symptoms) and 239 ACPA-positive patients presented aft er ≥12 weeks of symptoms (median

Th e radiographs were scored using the Sharp–van der Heijde method 12 by one reader, blinded to the clinical data, initially aware of the chronology. Patients with a negative